EP2442791
SKAMMTAFORM AF APIXABANI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.6.2010EP published:
27.11.2019EP application number:
10727611.5
EP translation filed:
20.2.2020Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
14.6.2030Expiry date:
14.6.2027Next due date:
30.6.2027
Title:
DOSAGE FORMS OF APIXABAN
Timeline
Today
15.6.2010EP application
27.11.2019EP Publication
20.2.2020Translation submitted
15.3.2020Registration published
14.6.2027Expires
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, 10017, New York, NY, US
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Hinterbergstrasse 16, 6312, Steinhausen, CH
Inventor
Name:
NAUSE, Richard, G.Address:
Groton, CT, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
187442 PDate:
16.6.2009Country:
US
Classification
Categories:
A61P 7/02, A61K 9/20, A61K 9/16, A61K 31/4545
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 5.5.2020
Expires: 14.6.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.5.2021
Expires: 14.6.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 6.5.2022
Expires: 14.6.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.5.2023
Expires: 14.6.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.5.2024
Expires: 14.6.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 2.6.2025
Expires: 14.6.2026
Payer: Árnason Faktor ehf.
Number: 17
Paid: 10.6.2026
Expires: 14.6.2027
Payer: Árnason Faktor ehf.